Derived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients Meeting Abstract


Authors: Mezquita, L.; Arbour, K.; Auclin, E.; Saravia, D.; Rizvi, H.; Hendriks, L.; Planchard, D.; Park, W.; Nadal, E.; Ruffinelli Rodriguez, J. C.; Ponce, S.; Audigier-Valette, C.; Marilniello, A. P.; Zalcman, G.; Majem, M.; Schiavone, G.; Dingemans, A. M. C.; Lopes, G.; Hellmann, M. D.; Besse, B.
Abstract Title: Derived neutrophil-to lymphocyte ratio (dNLR) change between baseline and cycle 2 is correlated with benefit during immune checkpoint inhibitors (ICI) in advanced non-small cell lung cancer (NSCLC) patients
Meeting Title: 43rd ESMO Congress (ESMO 2018)
Journal Title: Annals of Oncology
Volume: 29
Issue: Suppl. 8
Meeting Dates: 2018 Oct 19-23
Meeting Location: Munich, Germany
ISSN: 0923-7534
Publisher: Oxford University Press  
Date Published: 2018-10-01
Start Page: mdy292.029
Language: English
ACCESSION: WOS:000459277303177
PROVIDER: wos
DOI: 10.1093/annonc/mdy292.029
Notes: Meeting Abstract: 1407P -- Appears on page viii508 of the abstract book -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Matthew David Hellmann
    412 Hellmann
  2. Kathryn Cecilia Arbour
    89 Arbour
  3. Hira Abbas Rizvi
    123 Rizvi